SYH-2068

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameSYH-2068
Drug Alias NameSYH2068SYH-2068
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApolipoprotein(a) inhibitors
TargetsApolipoprotein(a)
Therapy Area/IndicationsHyperlipoproteinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCspc Heibei Zhongrun Pharmaceutiacl Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co LtdCspc Heibei Zhongrun Pharmaceutiacl Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A